Enzastaurin (ENZ) versus lomustine (CCNU) in the treatment of recurrent, intracranial glioblastoma multiforme (GBM): A phase III study

被引：17
|
作者：
Fine, H. A.
Puduvalli, V. K.
Chamberlain, M. C.
Carpentier, A. F.
Cher, L.
Mason, W. P.
van den Bent, M. J.
Hong, S.
Thornton, D.
Wick, W.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Hop La Pitie Salpetriere, Paris, France
[5] Austin Hlth, Heidelberg, Vic, Australia
[6] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[7] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[8] Eli Lilly & Co, Indianapolis, IN 46285 USA
[9] Univ Tubingen, Tubingen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.2005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2005
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] ENZASTAURIN (ENZ) VERSUS LOMUSTINE (CCNU) IN THE TREATMENT OF RECURRENT, INTRACRANIAL GLIOBLASTOMA (GBM): A PHASE III STUDY
    Wick, W.
    Puduvalli, V. K.
    Chamberlain, M.
    Carpentier, A.
    Cher, L.
    Mason, W.
    Van den Bent, M.
    Hong, S.
    Thornton, D.
    Fine, H.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1068 - 1068
  • [2] ENZASTAURIN VERSUS LOMUSTINE IN THE TREATMENT OF RECURRENT, INTRACRANIAL GLIOBLASTOMA: A PHASE III STUDY
    Puduvalli, Vinay K.
    Wick, Wolfgang
    Chamberlain, Marc
    Carpentier, Antoine
    Cher, Lawrence
    Mason, Warren
    Van Den Bent, Martin
    Hong, Sam
    Thornton, Donald E.
    Fine, Howard
    NEURO-ONCOLOGY, 2008, 10 (05) : 825 - 825
  • [3] Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
    Wick, Wolfgang
    Puduvalli, Vinay K.
    Chamberlain, Marc C.
    van den Bent, Martin J.
    Carpentier, Antoine F.
    Cher, Lawrence M.
    Mason, Warren
    Weller, Michael
    Hong, Shengyan
    Musib, Luna
    Liepa, Astra M.
    Thornton, Donald E.
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1168 - 1174
  • [4] Time to deterioration in dimensions of health-related quality of life (HRQL) for patients with recurrent glioblastoma multiforme (GBM): Results from the randomized, phase III trial of enzastaurin (ENZ) versus lomustine (CCNU)
    van den Bent, M. J.
    Wick, W.
    Liepa, A. M.
    Puduvalli, V. K.
    Carpentier, A. F.
    Cher, L.
    Mason, W. P.
    Taphoorn, M. J.
    Hong, S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Treatment of glioblastoma multiforme (GBM) with teniposide (VM26) and lomustine (CCNU) followed by radiotherapy
    Mañé, JM
    Barceló, JR
    Rubio, I
    Fernández, R
    Fuente, N
    Abón, G
    Muñoz, A
    López-Vivanco, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S120 - S120
  • [6] Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Page, M.
    Rabbitt, J.
    Fedoroff, A.
    Parvataneni, R.
    Nicol, S. J.
    Thornton, D.
    Prados, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] PHASE I/II STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (XRT) IN PATIENTS (PTS) WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, N.
    Lamborn, K.
    Chang, S.
    Page, M.
    Parvataneni, R.
    Chang, S.
    Liepa, A. M.
    Nicol, S.
    Thornton, D.
    Prados, M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1073 - 1074
  • [8] Phase II trial of enzastaurin (Enz) with bevacizumab (BV) in adults with recurrent glioblstoma (GBM).
    Moustakas, A.
    Iwamoto, F. M.
    Kreisl, T. N.
    Sul, J.
    Kim, L. J.
    Butman, J. A.
    Albert, P. S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] PHASE II AND PHARMACOGENOMICS (PGX) STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, Nicholas A.
    Lamborn, Kathleen L.
    Polley, Mei-Yin C.
    Hsieh, Emily
    Kivett, Valerie
    Page, Margaretta S.
    Parvataneni, Rupa
    Nicol, Steve
    Thornton, Don
    Prados, Michael
    NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621
  • [10] A RETROSPECTIVE REVIEW OF PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) TREATED WITH BEVACIZUMAB (AVASTIN), LOMUSTINE (CCNU) AND SIROLIMUS (RAPAMUNE)
    Ranjan, Tulika
    Peters, Katherine
    Vlahovic, Gordana
    Friedman, Henry
    Desjardins, Annick
    NEURO-ONCOLOGY, 2013, 15 : 127 - 127
12345